NASDAQ:APP 23 November 2025 - 11 December 2025

AppLovin shares closed at $703.28 on December 10, down 2.9% after a volatile session but remain near their all-time high of $745.61. The decline followed sector weakness and profit-taking ahead of a U.S. interest-rate decision. After-hours trading was quiet, with the stock holding just below the close. AppLovin has gained over 120% year-to-date.

AppLovin shares closed at $689.76 on Monday, down 0.3% after recent gains, then traded near $690 in after-hours. Volume was lighter than previous sessions. The stock is up 32.6% over two weeks and 113% year-to-date. Q3 revenue rose 68% to $1.405 billion, with net income up 92% to $836 million.

AppLovin shares closed at $691.94 on Friday, up 1.19%, marking a seven-session winning streak and a 33% gain over 10 days. The stock sits 7–10% below its 52-week high, with a market cap near $234 billion and trailing revenue of $4.71 billion. Recent filings show institutions increasing stakes while insiders, including the CEO and CTO, sold about $195 million in shares last quarter. Institutional ownership is now estimated at 41–42%.

AppLovin shares traded near $675–$682 midday Thursday, up 3%, extending a rally from $624 on Dec. 1. Q3 revenue rose 68% year over year to $1.41 billion, with net income of $836 million and an 82% adjusted EBITDA margin. Bank of America reiterated a Buy rating with an $860 target after AXON adoption surged. The company faces an SEC probe into data practices and ongoing short-seller pressure.

AppLovin shares rose about 4% to $623.59 on December 2, 2025, extending a sharp rally this year. The company appeared at the UBS Global Technology & AI Conference as new institutional buyers disclosed stakes. AppLovin’s market cap stands near $200 billion, with a trailing P/E around 75 and a 52-week range from $200.50 to $745.61. Regulatory probes and insider selling continue amid bullish Wall Street targets.

AppLovin shares traded near $600 on December 1, 2025, giving the company a market value of about $202 billion after a 485% gain over 52 weeks. Q3 revenue rose 68% to $1.41 billion, with net income nearly doubling and EBITDA margin at 82%. Management forecasts Q4 revenue of up to $1.6 billion. Analysts’ 12-month price targets average $658, with a consensus “Moderate Buy” rating.